The role of inflammation in vascular diseases

Journal of Leukocyte Biology

Volumn 67, Issue 5, 2000, Pages 591-602

  Sullivan, G W ^a   Sarembock, I J ^a   Linden, J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Angiogenesis; Aortic aneurysm; Atherogenesis; Ischemia reperfusion; No reflow

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; AORTA ANEURYSM; AORTA RUPTURE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0033840263     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.67.5.591     Document Type: Review

References (133)

1. Infection and inflammation as risk factors for myocardial infarction
2. The role of the neutrophil in myocardial ischemia and reperfusion
3. Hemorrhagic shock
4. Angiogenesis
5. Atherogenesis and inflammation
6. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture
7. Atherosclerosis - An inflammatory disease
8. Inflammatory aneurysms of the abdominal aorta
9. Inflammatory abdominal aortic aneurysms: A thirty-year review
10. Inflammation, metalloproteinases, and increased proteolysis: An emerging pathophysiological paradigm in aortic aneurysm
11. Inflammatory aneurysm of the ascending aorta and aortic arch
12. Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease?
13. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting
14. Endothelial response to cardiopulmonary bypass surgery
15. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass
16. Role of cytokines in myocardial ischemia and reperfusion
17. Inflammatory responses to ischemia and reperfusion in skeletal muscle
18. Native and modified low density lipoproteins increase the functional expression of the macrophage class B Scaventer receptor, CD36
19. Smoking and coronary artery disease
20. Cytokines and growth factors in atherogenesis
21. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages
22. Elevation of organ resistance due to leukocyte perfusion
23. Inflammatory alterations in the myocardial microcirculation
24. Inflammation in atheroma: Implications for plaque rupture and platelet-collagen interaction
25. The effect of antithrombin on the systemic inflammatory response in disseminated intravascular coagulation
26. Immunological control mechanisms in plaque formation
27. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit
28. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism - Implications for tubule formation
29. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
30. Role of inflammation and metalloproteinases in plaque disruption and thrombosis
31. Atherogenesis and ischemic heart disease
32. Interleukin-1: A mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids
33. Regulation of fibrinogen biosyntesis by cytokines, consequences on the vascular risk
34. Inflammation, atherosclerosis, and cardiovascular risk: An epidemiologic view
35. Expression of interleukin-10 in advanced human atherosclerotic plaques - Relation to inducible nitric oxide synthase expression and cell death
36. Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheromata
37. Chlamydia infections and heart disease linked through antigenic mimicry
38. Adhesion receptors of the immune system
39. Leukocyte-endothelial adhesion molecules
40. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse
41. Immunologic aspects of cardiovascular disease
42. The mast cell - A potential link between inflammation and cellular cholesterol deposition in atherogenesis
43. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction
44. Inflammatory and immunological nature of atherosclerosis
45. Cytomegalovirus and atherosclerosis
46. Herpes simplex virus and atherosclerosis
47. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms
48. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression
49. Pathogenesis of atherosclerosis: A possible relation to infection
50. Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts
51. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: Implications for the mode of progression of advanced coronary athererosclerosis
52. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions
53. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis
54. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclemsis and incident coronary heart disease: The atherosclerosis risk in communities (ARIC) study
55. Modulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 on human coronary smooth muscle cells by cytokines
56. Atherosclerosis and inflammation - Mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis
57. VLA proteins in the integrin family: Structures, functions, and their role on leukocytes
58. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL
59. + cells in atherosclerotic vessels
60. Costimulatory molecules in human atherosclerotic plaques: An indication of antigen specific T lymphocyte activation
61. Evidence for vascular tone regulation by resident or infiltrating leukocytes
62. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells in due to PDGF-AA
63. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: A prominent role for neovascularization?
64. Levels of expression of P-selectin, E-selectin, and intercellular adhesion molecule-1 in coronary atherectomy specimens from patients with stable and unstable angina pectoris
65. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: Results at autopsy
66. Type β transforming growth factor in human platelets: Release during platelet degranulation and action on vascular smooth muscle cells
67. Gamma interferon regulates smooth muscle cell proliferation and Ia expression in vivo and in vitro
68. Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis
69. Atherosclerotic plaque caps are locally weakened when macrophage density is increased
70. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle
71. Macrophage infiltration in acute coronary syndromes: Implications for plaque rupture
72. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
73. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: The remodeling paradox
74. Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries
75. Distribution of inflammatory cells in atherosclerotic plaques relates to the direction of flow
76. Development of the atherosclerotic core region: Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta
77. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability
78. Localization of tissue factor in the normal vessel wall and in atherosclerotic plaque
79. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
80. ACE inhibitor quinapril reduces the arterial expression of NF-kappa B-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis
81. Novel therapeutic directions against atherosclerosis
82. Antibiotics and risk of subsequent first-time acute myocardial infarction
83. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis
84. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms
85. Role of Inflammatory cells in aortic aneurysms
86. Do aneurysms cause atherosclerosis?
87. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response
88. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
89. Anti-CD 18 monoclonal antibody slows experimental aortic aneurysm expansion
90. The role of angiogenic cytokines in cardiovascular disease
91. Oxygen tension regulates the expression of angiogenesis factor by macrophage
92. Hypoxia-induced angiogenesis in chick chorioallantoic membranes: A role for adenosine
93. Mechanisms of angiogenesis
94. Molecular and cellular basis of myocardial angiogenesis
95. Activated macrophages induce vascular proliferation
96. Macrophages and angiogenesis
97. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells: Effects of tumor necrosis factor-α, interleukin 1 and phorbol ester
98. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia
99. CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression
100. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signalling in atherosclerosis
101. The speed of healing of myocardial infarction. A study of the pathologic anatomy in seventy-two cases
102. Deleterious effects of methylprednisolone in patients with myocardial infarction
103. Neutrophils and myocardial injury
104. Pharmacologic approaches to reperfusion injury
105. Experimental acute myocardial infarction. Histological and histochemical studies of early myocardial infarcts induced by temporary or permanent occlusion of a coronary artery
106. Myocardial reperfusion: A double-edged sword?
107. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat
108. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease
109. 2 inhibitor U-63557A
110. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog
111. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog
112. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs
113. The phlogistic role of C3 leukotactic fragment in myocardial infarcts of rats
114. Antibody-independent activation of human Cl after interaction with heart subcellular membranes
115. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction
116. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury
117. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury
118. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium
119. Sialyl Lewis-containing oligosaccharide attenuates myocardial reperfusion injury in cats
120. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (Anti-Mol, Anti-CD11b) that inhibits leukocyte adhesion
121. Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium
122. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion
123. Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice
124. Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia
125. Protective effects of adenosine in myocardial ischemia
126. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence
127. Neutrophil elastase enhances intercellular adhesion molecule-1 expression
128. 2- generation, respectively
129. Propentoxifylline enhancement of the actions of adenosine on neutrophil leukocytes
130. 3 receptors
131. 2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes
132. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells
133. Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs